Journal of Experimental Medicine, Vol 181, 915-926, Copyright © 1995 by Rockefeller University Press

ARTICLES

Pocket 4 of the HLA-DR(alpha,beta 1*0401) molecule is a major determinant of T cells recognition of peptide

XT Fu, CP Bono, SL Woulfe, C Swearingen, NL Summers, F Sinigaglia, A Sette, BD Schwartz and RW Karr
Department of Immunology, G. D. Searle & Co., St. Louis, Missouri 63198.

To investigate the functional roles of individual HLA-DR residues in T cell recognition, transfectants expressing wild-type or mutant DR(alpha,beta 1*0401) molecules with single amino acid substitutions at 14 polymorphic positions of the DR beta 1*0401 chain or 19 positions of the DR alpha chain were used as antigen-presenting cells for five T cell clones specific for the influenza hemagglutinin peptide, HA307-19. Of the six polymorphic positions in the DR beta floor that were examined, mutations at only two positions eliminated T cell recognition: positions 13 (four clones) and 28 (one clone). In contrast, individual mutations at DR beta positions 70, 71, 78, and 86 on the alpha helix eliminated recognition by each of the clones, and mutations at positions 74 and 67 eliminated recognition by four and two clones, respectively. Most of the DR alpha mutations had minimal or no effect on most of the clones, although one clone was very sensitive to changes in the DR alpha chain, with loss of recognition in response to 10 mutants. Mutants that abrogated recognition by all of the clones were assessed for peptide binding, and only the beta 86 mutation drastically decreased peptide binding. Single amino acid substitutions at polymorphic positions in the central part of the DR beta alpha helix disrupted T cell recognition much more frequently than substitutions in the floor, suggesting that DR beta residues on the alpha helix make relatively greater contributions than those in the floor to the ability of the DR(alpha,beta 1*0401) molecule to present HA307-19. The data indicate that DR beta residues 13, 70, 71, 74, and 78, which are located in pocket 4 of the peptide binding site in the crystal structure of the DR1 molecule, exert a major and disproportionate influence on the outcome of T cell recognition, compared with other polymorphic residues.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Shadick, N A, Heller, J E, Weinblatt, M E, Maher, N E, Cui, J, Ginsburg, G, Coblyn, J, Anderson, R, Solomon, D H, Roubenoff, R, Parker, A (2007). Opposing effects of the D70 mutation and the shared epitope in HLA-DR4 on disease activity and certain disease phenotypes in rheumatoid arthritis. Ann Rheum Dis 66: 1497-1502 [Abstract] [Full Text]  
• Diaz, G., Amicosante, M., Jaraquemada, D., Butler, R. H., Guillen, M. V., Sanchez, M., Nombela, C., Arroyo, J. (2003). Functional analysis of HLA-DP polymorphism: a crucial role for DP{beta} residues 9, 11, 35, 55, 56, 69 and 84-87 in T cell allorecognition and peptide binding. Int Immunol 15: 565-576 [Abstract] [Full Text]  
• Magira, E. E., Papaioakim, M., Nachamkin, I., Asbury, A. K., Li, C. Y., Ho, T. W., Griffin, J. W., McKhann, G. M., Monos, D. S. (2003). Differential Distribution of HLA-DQ{beta}/DR{beta} Epitopes in the Two Forms of Guillain-Barre Syndrome, Acute Motor Axonal Neuropathy and Acute Inflammatory Demyelinating Polyneuropathy (AIDP): Identification of DQ{beta} Epitopes Associated with Susceptibility to and Protection from AIDP. J. Immunol. 170: 3074-3080 [Abstract] [Full Text]  
• Hennecke, J., Wiley, D. C. (2002). Structure of a Complex of the Human {alpha}/{beta} T Cell Receptor (TCR) HA1.7, Influenza Hemagglutinin Peptide, and Major Histocompatibility Complex Class II Molecule, HLA-DR4 (DRA0101 and DRB10401): Insight into TCR Cross-Restriction and Alloreactivity. J. Exp. Med. 195: 571-581 [Abstract] [Full Text]  
• Fraser, P A, Lu, L-Y, DeCeulaer, K, Schur, P H, Fici, D, Awdeh, Z, Ding, W-Z, Levitan, E, Lew, R, Uko, G, Gonzalez, C (1999). CD4 TCRBV CDR3 Analysis in prevalent SLE Cases from two ethnic Groups. Lupus 8: 311-319 [Abstract]  
• Matsuo, H., Corlett, L., Hawke, S., Nicolle, M., Driscoll, P., Deshpande, S., Spack, E., Willcox, N. (1999). Distant interactions between dimorphisms in HLA-DR4 radically affect recognition of defined peptides by a specific T cell clone. Int Immunol 11: 835-843 [Abstract] [Full Text]  
• Nagaoka, Y., Kabeya, H., Onuma, M., Kasai, N., Okada, K., Aida, Y. (1999). Ovine MHC Class II DRB1 Alleles Associated with Resistance or Susceptibility to Development of Bovine Leukemia Virus-induced Ovine Lymphoma. Cancer Res. 59: 975-981 [Abstract] [Full Text]  
• Smith, K. J., Pyrdol, J., Gauthier, L., Wiley, D. C., Wucherpfennig, K. W. (1998). Crystal Structure of HLA-DR2 (DRA*0101, DRB1*1501) Complexed with a Peptide from Human Myelin Basic Protein. J. Exp. Med. 188: 1511-1520 [Abstract] [Full Text]  
• Doherty, D. G., Penzotti, J. E., Koelle, D. M., Kwok, W. W., Lybrand, T. P., Masewicz, S., Nepom, G. T. (1998). Structural Basis of Specificity and Degeneracy of T Cell Recognition: Pluriallelic Restriction of T Cell Responses to a Peptide Antigen Involves Both Specific and Promiscuous Interactions Between the T Cell Receptor, Peptide, and HLA-DR. J. Immunol. 161: 3527-3535 [Abstract] [Full Text]  
• Woulfe, S. L., Bono, C. P., Zacheis, M. L., Welply, J. K., Kirschmann, D. A., Baudino, T. A., Wang, Y., Stone, D. A., Hanson, G. J., Vuletich, J. L., Bedell, L. J., Schwartz, B. D., Howard, S. C. (1997). A Peptidomimetic that Specifically Inhibits Human Leukocyte Antigen DRB1*0401-restricted T Cell Proliferation. J. Pharmacol. Exp. Ther. 281: 663-669 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS